Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 349320, 7 pages
http://dx.doi.org/10.1155/2012/349320
Research Article

Nicotine Exposure Exacerbates Development of Cataracts in a Type 1 Diabetic Rat Model

1Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA
2Center for Biomedical Engineering, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA
3Endocrinology, Department of Internal Medicine, Division of Endocrinology & Metabolism, University of Texas Medical Branch at Galveston, Galveston, TX 77555, USA

Received 6 April 2012; Accepted 6 August 2012

Academic Editor: Åke Lernmark

Copyright © 2012 Nima Tirgan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Janghorbani, R. B. Jones, and S. P. Allison, “Incidence of and risk factors for cataract among diabetes clinic attenders,” Ophthalmic Epidemiology, vol. 7, no. 1, pp. 13–25, 2000. View at Google Scholar · View at Scopus
  2. N. Rowe, P. Mitchell, R. G. Cumming, and J. J. Wang, “Diabetes, fasting blood glucose and age-related cataract: the blue mountains eye study,” Ophthalmic Epidemiology, vol. 7, no. 2, pp. 103–114, 2000. View at Google Scholar · View at Scopus
  3. H. Rink, “Cataractogenic risk factors,” Developments in Ophthalmology, vol. 15, pp. 66–76, 1987. View at Google Scholar · View at Scopus
  4. J. J. Harding, M. Egerton, R. Van Heyningen, and R. S. Harding, “Diabetes, glaucoma, sex, and cataract: analysis of combined data from two case control studies,” British Journal of Ophthalmology, vol. 77, no. 1, pp. 2–6, 1993. View at Google Scholar · View at Scopus
  5. J. J. Harding, R. S. Harding, and M. Egerton, “Risk factors for cataract in Oxfordshire: diabetes, peripheral neuropathy, myopia, glaucoma and diarrhoea,” Acta Ophthalmologica, vol. 67, no. 5, pp. 510–517, 1989. View at Google Scholar · View at Scopus
  6. F. P. Esteves, R. Sanyal, J. A. Nye, C. A. Santana, L. Verdes, and P. Raggia, “Adenosine stress rubidium-82 PET/computed tomography in patients with known and suspected coronary artery disease,” Nuclear Medicine Communications, vol. 29, no. 8, pp. 674–678, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. R. G. Cumming and P. Mitchell, “Alcohol, smoking, and cataracts: the Blue Mountains eye study,” Archives of Ophthalmology, vol. 115, no. 10, pp. 1296–1303, 1997. View at Google Scholar · View at Scopus
  8. C. Delcourt, J. P. Cristol, F. Tessier, C. L. Léger, F. Michel, and L. Papoz, “Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA Study,” American Journal of Epidemiology, vol. 151, no. 5, pp. 497–504, 2000. View at Google Scholar · View at Scopus
  9. J. J. Harding and R. Van Heyningen, “Drugs, including alcohol, that act as risk factors for cataract, and possible protection against cataract by aspirin-like analgesics and cyclopenthiazide,” British Journal of Ophthalmology, vol. 72, no. 11, pp. 809–814, 1988. View at Google Scholar · View at Scopus
  10. M. C. Leske, L. T. Chylack Jr., and S. Y. Wu, “The lens opacities case-control study. Risk factors for cataract,” Archives of Ophthalmology, vol. 109, no. 2, pp. 244–251, 1991. View at Google Scholar · View at Scopus
  11. S. West, B. Munoz, O. D. Schein et al., “Cigarette smoking and risk for progression of nuclear opacities,” Archives of Ophthalmology, vol. 113, no. 11, pp. 1377–1380, 1995. View at Google Scholar · View at Scopus
  12. P. Raju, R. George, S. Ve Ramesh, H. Arvind, M. Baskaran, and L. Vijaya, “Influence of tobacco use on cataract development,” British Journal of Ophthalmology, vol. 90, no. 11, pp. 1374–1377, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Zhang, F. Y. Chai, H. Yan, Y. Guo, and J. J. Harding, “Effects of N-acetylcysteine and glutathione ethyl ester drops on streptozotocin-induced diabetic cataract in rats,” Molecular Vision, vol. 14, pp. 862–870, 2008. View at Google Scholar · View at Scopus
  14. A. Joy, M. S. Currie, S. T. Donohue, and K. J. Al-Ghoul, “Aberrant basal fiber end migration underlies structural malformations in a streptozotocin-induced diabetic rat model,” Experimental Eye Research, vol. 89, no. 3, pp. 344–357, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. G. Matta, D. J. Balfour, N. L. Benowitz et al., “Guidelines on nicotine dose selection for in vivo research,” Psychopharmacology, vol. 190, no. 3, pp. 269–319, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. C. G. McAllister-Sistilli, A. R. Caggiula, S. Knopf, C. A. Rose, A. L. Miller, and E. C. Donny, “The effects of nicotine on the immune system,” Psychoneuroendocrinology, vol. 23, no. 2, pp. 175–187, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Eliasson, S. Attvall, M. R. Taskinen, and U. Smith, “The insulin resistance syndrome in smokers is related to smoking habits,” Arteriosclerosis and Thrombosis, vol. 14, no. 12, pp. 1946–1950, 1994. View at Google Scholar · View at Scopus
  18. R. E. Schmidt, D. A. Dorsey, L. N. Beaudet, K. M. Reiser, J. R. Williamson, and R. G. Tilton, “Effect of aminoguanidine on the frequency of neuroaxonal dystrophy in the superior mesenteric sympathetic autonomic ganglia of rats with streptozocin-induced diabetes,” Diabetes, vol. 45, no. 3, pp. 284–290, 1996. View at Google Scholar · View at Scopus
  19. R. Blakytny and J. J. Harding, “Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen,” Experimental Eye Research, vol. 54, no. 4, pp. 509–518, 1992. View at Publisher · View at Google Scholar · View at Scopus
  20. W. G. Christen, J. E. Manson, J. M. Seddon et al., “A prospective study of cigarette smoking and risk of cataract in men,” Journal of the American Medical Association, vol. 268, no. 8, pp. 989–993, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. D. E. Flaye, K. N. Sullivan, T. R. Cullinan, J. H. Silver, and R. A. F. Whitelocke, “Cataracts and cigarette smoking. The City Eye Study,” Eye, vol. 3, no. 4, pp. 379–384, 1989. View at Google Scholar · View at Scopus
  22. B. E. K. Klein, R. Klein, and S. E. Moss, “Prevalence of cataracts in a population-based study of persons with diabetes mellitus,” Ophthalmology, vol. 92, no. 9, pp. 1191–1196, 1985. View at Google Scholar · View at Scopus
  23. M. B. Newman, G. W. Arendash, R. D. Shytle, P. C. Bickford, T. Tighe, and P. R. Sanberg, “Nicotine's oxidative and antioxidant properties in CNS,” Life Sciences, vol. 71, no. 24, pp. 2807–2820, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. M. K. Reddy and V. Labhasetwar, “Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury,” FASEB Journal, vol. 23, no. 5, pp. 1384–1395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. K. Dey and S. Roy, “Role of reduced glutathione in the amelioration of nicotine-induced oxidative stress,” Bulletin of Environmental Contamination and Toxicology, vol. 84, no. 4, pp. 385–389, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Merriman-Smith, P. Donaldson, and J. Kistler, “Differential expression of facilitative glucose transporters GLUT1 and GLUT3 in the lens,” Investigative Ophthalmology and Visual Science, vol. 40, no. 13, pp. 3224–3230, 1999. View at Google Scholar · View at Scopus
  27. N. E. Grunberg, K. A. Popp, D. J. Bowen, S. M. Nespor, S. E. Winders, and S. E. Eury, “Effects of chronic nicotine administration on insulin, glucose, epinephrine, and norepinephrine,” Life Sciences, vol. 42, no. 2, pp. 161–170, 1988. View at Google Scholar · View at Scopus
  28. D. D. Oyebola, G. O. Idolor, E. O. Taiwo, A. R. Alada, O. Owoeye, and G. O. Isehunwa, “Effect of nicotine on glucose uptake in the rabbit small intestine,” African Journal of Medicine and Medical Sciences, vol. 38, no. 2, pp. 119–130, 2009. View at Google Scholar · View at Scopus
  29. T. M. Morgan, L. Crawford, A. Stoller, D. Toth, K. T. J. Yeo, and J. A. Baron, “Acute effects of nicotine on serum glucose insulin growth hormone and cortisol in healthy smokers,” Metabolism, vol. 53, no. 5, pp. 578–582, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. A. R. Alada, “Effects of calcium channel blockers on nicotine-induced hyperglycemia in the rat,” African Journal of Medicine and Medical Sciences, vol. 30, no. 1-2, pp. 57–59, 2001. View at Google Scholar · View at Scopus
  31. O. O. Ogwumike and A. A. Fasanmade, “Effects of adrenoceptor blockers on the glycemic response to nicotine in thyroidectomised rats,” African Journal of Medicine and Medical Sciences, vol. 29, no. 2, pp. 161–165, 2000. View at Google Scholar · View at Scopus
  32. B. E. K. Klein, R. Klein, K. E. Lee, M. D. Knudtson, and M. Y. Tsai, “Markers of inflammation, vascular endothelial dysfunction, and age-related cataract,” American Journal of Ophthalmology, vol. 141, no. 1, pp. 116–122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Funatsu, H. Yamashita, H. Noma, T. Mimura, T. Yamashita, and S. Hori, “Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema,” American Journal of Ophthalmology, vol. 133, no. 1, pp. 70–77, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Zeidel, B. Beilin, I. Yardeni, E. Mayburd, G. Smirnov, and H. Bessler, “Immune response in asymptomatic smokers,” Acta Anaesthesiologica Scandinavica, vol. 46, no. 8, pp. 959–964, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. J. G. Mabley, P. Pacher, G. J. Southan, A. L. Salzman, and C. Szabó, “Nicotine reduces the incidence of type I diabetes in mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 300, no. 3, pp. 876–881, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. S. M. Rankin, D. M. Conroy, and T. J. Williams, “Eotaxin and eosinophil recruitment: implications for human disease,” Molecular Medicine Today, vol. 6, no. 1, pp. 20–27, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. C. A. Lange, P. Stavrakas, U. F. Luhmann et al., “Intraocular oxygen distribution in advanced proliferative diabetic retinopathy,” American Journal of Ophthalmology, vol. 152, no. 3, pp. 406.e3–412.e3, 2011. View at Google Scholar
  38. P. Hanifi-Moghaddam, S. Kappler, J. Seissler et al., “Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus,” Diabetic Medicine, vol. 23, no. 2, pp. 156–163, 2006. View at Publisher · View at Google Scholar · View at Scopus